American Journal of Microbiological Research
ISSN (Print): 2328-4129 ISSN (Online): 2328-4137 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Microbiological Research. 2019, 7(4), 108-117
DOI: 10.12691/ajmr-7-4-2
Open AccessArticle

Molecular Identification and Virulence Factors Determination in Candida Species Isolated from Egyptian Patients

Nehal Ahmed1, Dina E Rizk1, Manal El Said2, 3, , Rasha MF Barwa1, Mohammed Adel Elsokary1 and Ramadan HI Hassan1

1Microbiology and Immunology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

2Microbiology Department, Theodor Bilharz Research Institute, Giza, Egypt

3Infection Control Unit, Theodor Bilharz Research Institute, Giza, Egypt

Pub. Date: October 24, 2019

Cite this paper:
Nehal Ahmed, Dina E Rizk, Manal El Said, Rasha MF Barwa, Mohammed Adel Elsokary and Ramadan HI Hassan. Molecular Identification and Virulence Factors Determination in Candida Species Isolated from Egyptian Patients. American Journal of Microbiological Research. 2019; 7(4):108-117. doi: 10.12691/ajmr-7-4-2


Candida-related infections are becoming a universal threat to the health of human who undergo immunosuppressive therapy or aggressive medical intervention. Objectives: The aim was to study the distribution of Candida species among winter and summer seasons and to determine the expression of their virulence factors. Methods: A total of 164 Candida isolates were collected from clinical specimens at Mansoura University Hospitals. Candida species were identified by polymerase chain reaction (PCR). Extracellular phospholipase, secretory aspartyl proteinase (SAP) and coagulase enzymes and biofilm formation were determined. SAP 9 and 10 genes were detected by PCR. Results: Non-albicans (NAC) isolates were more dominant than C. albicans isolates (P value < 0.0001). C. tropicalis was the most prevalent (59.2%) followed by C. albicans (31.1%), then C. glabrata, C. krusie, unidentified NAC and C. kefyr in 3.7%, 2.4%, 2.4% and 1.2% respectively. Extracellular phospholipase activity was detected in 31.7% of Candida isolates. All C. albicans had phospholipase activity (100%) and one isolate of C. tropicalis was positive while other species were negative. SAPs activities were determined in 61.6% of Candida isolates and were detected in 70.1% and 62.7% among C. tropicalis and C. albicans isolates respectively. SAP9 and SAP 10 genes were detected in 27.7% and 12.9% of Candida isolates showed positive SAPs activity respectively and they were all C. albicans strains. Other species did not harbor either SAP9 or SAP10. Coagulase activity was detected in 80.4% of Candida isolates with higher activity in C. albicans (88.2%), followed by C. tropicalis (81.4%), then other NAC isolates. Biofilm formation was determined in 69.5% of Candida isolates and was more prevalent in C. tropicalis (82.5%) followed by C. albicans (19.6%), C. krusie (100%), unidentified NAC (75%), C. glabrata (33.3%) and C. kefyr (50%). Conclusion: NAC with a preponderance of C. tropicalis was the most common isolated Candida species. Biofilm production, proteinase, phospholipases and coagulase enzymes were observed in both C. albicans and NAC. SAP9 and SAP 10 genes were detected only in C. albicans strains.

candida polymerase chain reaction phospholipases proteinase coagulase biofilm SAP 9 10 genes

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  El-Houssaini HH , Elnabawy OM , Nasser HA, Elkhatib WF. Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients. BMC Infect Dis. 2019; 19 (1):54.
[2]  Jafari Z, Motamedi M, Jalalizand N, Shokoohi GR, Charsizadeh A, Mirhendi H. Comparison of CHROMagar, polymerase chain reaction-restriction fragment length polymorphism, and polymerase chain reaction-fragment size for the identification of Candida species. Curr Med Mycol. 2017; 3(3):10-15.
[3]  Pais P, Galocha M, Viana R, Cavalheiro M, Pereira D, Teixeira MC. Microevolution of the pathogenic yeast Candida albicans and Candida glabrata during antifungal therapy and host infection. Microb Cell 2019; 6 (3):142-159.
[4]  Zawrotniak M, Bochenska O, Karkowska-Kuleta J, Seweryn-Ozog K, Aoki W, Ueda M, Kozik A, Rapala-Kozik M. Aspartic Proteases and Major Cell Wall Components in Candida albicans trigger the Release of Neutrophil Extracellular Traps. Front Cell Infect Microbiol 2017; 7:414.
[5]  Benzaid C, Belmadani A, Djeribi R, Rouabhia M. The Effects of Mentha × piperita Essential Oil on C. albicans Growth, Transition, Biofilm Formation, and the Expression of Secreted Aspartyl Proteinases Genes. Antibiotics (Basel) 2019; 30; 8(1).
[6]  Bassyouni RH, Wegdan AA, Abdelmoneim A, Said W, Abo Elnaga F. Phospholipase and Aspartyl Proteinase Activities of Candida Species Causing Vulvovaginal Candidiasis in Patients with Type 2 Diabetes Mellitus. J Microbiol Biotechnol 2015; 25 (10):1734-1741.
[7]  Subramanya SH, Baral BP, Sharan NK, Nayak N, Metok Y, Sathian B, Bairy I, Gokhale S. Antifungal susceptibility and phenotypic virulence markers of Candida species isolated from Nepal. BMC Res Notes 2017;10 (1):543.
[8]  Kadry AA, El-Ganiny AM, El-Baz AM. Relationship between Sap prevalence and biofilm formation among resistant clinical isolates of Candida albicans. Afr Health Sci. 2018; 18(4): 1166-1174.
[9]  Fidler G, Leiter Eva , Kocsube S, Biro S, Paholcsek M. Validation of a simplex PCR assay enabling reliable identification of clinically relevant Candida species. BMC Infectious Diseases 2018; 18:393.
[10]  Morad HOJ, Wild A-M , Wiehr S , Davies G , Maurer A, Pichler BJ, Thornton CR..Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR. Front Microbiol. 2018; 9: 1996.
[11]  Arastehfar A, Fang W, Pan W, Lackner M, Liao W, Badiee P, Zomorodian K, Badali H, Hagen F, Lass-Flörl C, Boekhout T. YEAST PANEL multiplexes PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries. Diagn Microbiol Infect Dis. 2019; 93(2):112-119.
[12]  Patterson TF, Donnelly JP. New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies. J. Fungi 2019; 5(1).
[13]  Chen E, Benso B, Seleem D, Ferreira LEN, Pasetto S, Pardi V, Murata RM. Fungal-Host Interaction: Curcumin Modulates Proteolytic Enzyme Activity of Candida albicans and Inflammatory Host Response in Vitro. Int J Dent. 2018; 2018: 2393146.
[14]  Vieira de Melo AP, Zuza-Alves DL, da Silva-Rocha WP, Ferreira Canário de Souza LB, Francisco EC, Salles de Azevedo Melo A, Maranhão Chaves G. Virulence factors of Candida spp. obtained from blood cultures of patients with candidemia attended at tertiary hospitals in Northeast Brazil. J Mycol Med. 2019; S1156-5233(18)30304-4.
[15]  Hosseini SS, Ghaemi E, Koohsar F. Influence of ZnO nanoparticles on Candida albicans isolates biofilm formed on the urinary catheter. Iran J Microbiol 2018; 10(6):424-432.
[16]  Pandey N, Gupta MK, Ragini T. Extracellular hydrolytic enzyme activities of the different Candida spp. isolated from the blood of the Intensive Care Unit-admitted patients. J Lab Physicians. 2018; 10(4): 392-396.
[17]  Ikonomova SP, Moghaddam-Taaheri P, Jabra-Rizk MA, Wang Y, Karlsson AJ. Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency. FEBS J. 2018; 285(1):146-159.
[18]  Lahkar V, Saikia L, Patgiri SJ, Nath R, Das PP. Estimation of biofilm, proteinase & phospholipase production of the Candida species isolated from the oropharyngeal samples in HIV-infected patients. Indian J Med Res. 2017; 145 (5):635-640.
[19]  Zafar S, Batool H, Nadeem SG. Coagulase Activity: A Virulence Trait in Pathogenic Candida species. RADS Journal of Biological Research and Applied Science 2016; 7 (1): 24-27.
[20]  Rodrigues AG, Pina-Vaz C, Costa-de-Oliveira S, Tavares C.: Expression of plasma coagulase among pathogenic Candida species. J Clin Microbiol 2003; 41: 5792-5793
[21]  Yigit N, Aktas E, Ayyildiz A. Detection of Coagulase Activity in Pathogenic Candida Species. J Int Med Res 2008; 36 (6):1378-82.
[22]  Padmajakshi G, Saini S , deorukhkar S, Ramana KV. Coagulase Activity of Candida Spp Isolated from HIV Seropositive Patients Using Different Animal Plasma. American Journal of Microbiological Research 2014; 2 (2): 57-59.
[23]  Yang L, Liu X, Zhong L, Sui Y, Quan G, Huang Y, Wang F, Ma T. Dioscin Inhibits Virulence Factors of Candida albicans. Biomed Res Int. 2018; 2018: 4651726.
[24]  Shirkhani S, Sepahvand A, Mirzaee M, Anbari K. Phospholipase and proteinase activities of Candida spp. isolates from vulvovaginitis in Iran. J Mycol Med 2016; 26(3):255-260.
[25]  Altizer S, Bartel R, Han BA. Animal migration and infectious disease risk. Science; 2011 331, 296- 302.
[26]  Langwig KE, Frick WF, Reynolds R, Parise KL, Drees KP, Hoyt JR, Cheng TL, Kunz TH, Foster JT, A. Kilpatrick M. Host and pathogen ecology drive the seasonal dynamics of a fungal disease, white-nose syndrome. Proc. R. Soc. B 2015; 282: 20142335.
[27]  Dhondt AA, States SL, Dhondt KV, Schat KA. Understanding the origin of seasonal epidemics of mycoplasmal conjunctivitis. J Anim Ecol 2012; 81, 996-1003.
[28]  Marinho SA, Teixeira AB, Santos OS, Cazanova RF, Ferreira CAS, Cherubini K, de Oliveira SD. Identification of candida spp. by phenotypic tests and PCR. Braz J Microbiol. 2010; 41: 286-294.
[29]  Messeir I, Abrantes PMDS, Africa CWJ. Strengths and Limitations of different Chromogenic Media for the Identification of Candida Species. J Microbiol Research 2012; 2(5): 133-140.
[30]  Martinez JM, Gómez EV, Pemán J, Cantón E, García MG, del Castillo Agudo L. Identification of pathogenic yeast species by polymerase chain reaction amplification of the RPS0 gene intron fragment. J Appl Microbiol 2010; 108 (6):1917-1927.
[31]  Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A. PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast 2002; 19: 973-989.
[32]  Mahmoudabadi AZ, Zarrin M, Miry S. Phospholipase activity of Candida albicans isolated from vagina and urine samples. Jundishapur J Microbiol 2010; 3(4): 169-173.
[33]  Patil S, Ugargol AR, Srikanth NS. Comparison of two methods or detection of secreted aspartyl proteinase in urinary isolates of candida species. National Journal of medical research 2014; 4: 119-121.
[34]  Monroy-Pérez E, Paniagua-Contreras G, Vaca-Paniagua F, Negrete-Abascal E , Vaca S. SAP Expression in Candida albicans Strains Isolated from Mexican Patients with Vaginal Candidosis. International Journal of Clinical Medicine 2013; 4: 25-31.
[35]  Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 2003; 41:2961-2967.
[36]  Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation J Microbiol Methods 2000; 40 (2): 175-179.
[37]  Kim JS, Won YH, Chun IK, Kim YP. Clinical and mycological studies on dermatomycosis. Korean J Dermatol. 1992; 30: 68-75.
[38]  Moon HJ, Lee JB, Kim SJ, Lee SC, Won YH. Clinical and mycological studies on dermatomycosis (1991-2000) Korean J Med Mycol. 2002; 7:78-85.
[39]  Edi-Osagie NE , Emmerson AJ. Seasonality of invasive Candida infection in neonates. Acta Paediatr 2005; 94(1):72-74.
[40]  Shin HS, Park YB, Shin DS. Isolation frequency of Candida species from clinical specimens. Kor J Mycol. 2010; 38: 146-151.
[41]  Kim GY, Jeon JS , Kim JK. Isolation Frequency Characteristics of Candida Species from Clinical Specimens. Mycobiology 2016; 44(2): 99-104.
[42]  de Almeida AA, Mesquita CSS, Svidzinski TIE, de Oliveira KMP. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop 2013; 46(3): 335-339.
[43]  Paswan AK, Raju DC, Singh DK, Khuba S, Dubey RK . Isolation and distribution of Candida species among different clinical situations in critically ill patients: prospective study. International Journal of Biomedical Research 2012; 3(2): 120-126.
[44]  Kothari A, Sagar V. Epidemiology of Candida blood stream infections in a tertiary care institute in India. Indian J Med Microbiol 2009;27(2): 171-172.
[45]  Wang T , Shao J , Da W , Li Q , Shi G , Wu D , Wang C. Strong Synergism of Palmatine and Fluconazole/Itraconazole Against Planktonic and Biofilm Cells of Candida Species and Efflux-Associated Antifungal Mechanism. Front Microbiol. 2018; 9: 2892.
[46]  Adjapong G, Hale M, Garrill A. An investigation of the distribution of Candida species in genitourinary candidiasis and pelvic inflammatory disease from three locations in Ghana. African Journal of Microbiology Research 2014; 8(6): 470-475.
[47]  da Silva-Rocha W P, de Brito Lemos VL, Svidizisnki TIE, Milan EP, Chaves GM. Candida species distribution, genotyping and virulence factors of Candida albicans isolated from the oral cavity of kidney transplant recipients of two geographic regions of Brazil. BMC Oral Health 2014; 14: 20.
[48]  Rossoni RD, Barbosa JO, Vilela SFG, Cardoso AO, Junqueira JJC. Comparison of the hemolytic activity between C. albicans and nonalbicans Candida species. Braz Oral Res 2013; 27(6): 484-489.
[49]  Martins JS, Junqueira JC, Faria RL, Santiago NF, Rossoni RD, Colombo CE, Jorge AO. Antimicrobial photodynamic therapy in rat experimental candidiasis: evaluation of pathogenicity factors of Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111(1): 71-77.
[50]  Pinto E, Ribeiro IC, Ferreira NJ, Fortes CE, Fonseca PA, Figueiral MH. Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denturerelated stomatitis and control individuals. J Oral Pathol Med 2008;37(10):587-592.
[51]  Vidotto V, Yumi Koga-Ito C, Milano R, Fianchino B, Pontón J. Correlation between germ tube production, phospholipase activity and serotype distribution in Candida albicans. Rev. Iberoam. Micol 1999; 16: 208-210.
[52]  Deca-junior A, Silva AF, Rosa FC, Monteiro SG, de Maria Silva Figueiredo P, de Andrade Monteiro C. In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida. Rev Soc Bras Med Trop 2011; 44(3): 334-338.
[53]  Gokce G, Cerikcioglu N, Yagci A. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia 2007; 164(6): 265-269.
[54]  Kaur R, Goyal R, Dhakad MS, Bhalla P, Diwan R. A Study of Virulence Factors: Proteinase, Phospholipase, and Biofilm in HIV/ AIDS Patients. J HIV AIDS 2015; 1(2).
[55]  Sachin CD, Ruchi K, Santosh S. In vitro evaluation of proteinase, phospholipase and haemolysin activities of Candida species isolated from clinical specimens. International Journal of Medicine and Biomedical Research 2012; 1 (2): 153-157.
[56]  Nawaz A, Mäkinen A, Pärnänen P, Meurman JH. Proteolytic activity of non-albicans Candida and Candida albicans in oral cancer patients. New Microbiol 2018; 41(4): 296-301.
[57]  Parra-Ortega B, Cruz-Torres H, Villa-Tanaca L, Hernández-Rodríguez C. Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species. Mem. Inst. Oswaldo Cruz 2009; 104(3): 505-512.
[58]  Joo MY, Shin JH, Jang H-C, Song ES, Kee SJ, Shin MG, Suh SP, Ryang DW. Expression of SAP5 and SAP9 in Candida albicans biofilms: comparison of bloodstream isolates with isolates from other sources. Medical Mycology 2013, 51(8): 892-896.
[59]  Staniszewska M, Bondaryk M, Malewski T, Kurzątkowski W. Quantitative Expression of Candida albicans Aspartyl Proteinase Genes SAP7, SAP8, SAP9, SAP10 in Human Serum in vitro. Polish Journal of Microbiology 2014; 63(1):15-20.
[60]  Yigit N , Aktas E , Dagistan S , Ayyildiz A . Investigating Biofilm Production, Coagulase and Hemolytic Activity in Candida Species Isolated From Denture Stomatitis Patients Eurasian J Med. 2011; 43(1): 27-32.
[61]  Mohandas V, Ballal M. Distribution of Candida Species in different clinical samples and their virulence: Biofilm formation, proteinase and phospholipase production: A study on hospitalized patients in Southern India. J Glob Infect Dis 2011; 3(1): 4-8.
[62]  Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol. Rev 2012; 36(2): 288-305
[63]  Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungalproducts and new therapeutic options. J Med Microbiol 2013;62(1):10-24.
[64]  Jalal M, Ansari MA, Alzohairy MA, Ali SG, Khan HM , Almatroudi A, Siddiqui MI. Anticandidal activity of biosynthesized silver nanoparticles: effect on growth, cell morphology, and key virulence attributes of Candida species. Int J Nanomedicine 2019; 14: 4667-4679.
[65]  Rai LS, Singha R, Sanchez H, Chakraborty T, Chand B, Bachellier-Bassi S, Chowdhury S, d'Enfert C, Andes DR, Sanyal K. The Candida albicans biofilm gene circuit modulated at the chromatin level by a recent molecular histone innovation. PLoS Biol 2019;17(8): e3000422.